• Head & Neck
Name No. Patient Profile Purpose
Javelin Head and Neck 100 17-22

Patients with high-risk, locally advanced squamous cell carcinoma of the head and neck who are candidates for definitive standard of care chemoradiation with cisplatin.

To demonstrate that treatment with avelumab in combination with standard of care chemoradiation is superior to standard of care chemoradiation alone in prolonging progression-free survival in frontline patients with high-risk, locally advanced squamous cell carcinoma of the head and neck who are candidates for definitive standard of care chemoradiation with cisplatin.


  • Head & Neck
Name No. Patient Profile Purpose
BMS CA 209-651 17-20

Recurrent or metastatic squamous cell carcinoma of the head and neck.

The main purpose is to compare the effectiveness of nivolumab and ipilimumab with the EXTREME study regimen as first line treatment.